Coverart for item
The Resource FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [sic] meets standards for safety and efficacy, March 1, 2005

FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [sic] meets standards for safety and efficacy, March 1, 2005

Label
FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [sic] meets standards for safety and efficacy, March 1, 2005
Title
FDA's drug approval process
Title remainder
up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [sic] meets standards for safety and efficacy, March 1, 2005
Title variation
Food and Drug Administration's drug approval process
Creator
Subject
Language
eng
Member of
Additional physical form
Also available via Internet from the GPO Access web site. Address as of 8/22/05 : http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=109%5Fsenate%5Fhearings&docid=f:99761.pdf; current access is available via PURL.
Cataloging source
SEN
Government publication
federal national government publication
Illustrations
illustrations
Index
no index present
Literary form
non fiction
Nature of contents
bibliography
http://bibfra.me/vocab/lite/organizationName
United States
Series statement
S. hrg.
Series volume
109-67
http://library.link/vocab/subjectName
  • United States
  • Drugs
  • Pharmaceutical policy
Label
FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [sic] meets standards for safety and efficacy, March 1, 2005
Link
http://purl.access.gpo.gov/GPO/LPS63058
Instantiates
Publication
Note
  • "Printed for the use of the Committee on Health, Education, Labor, and Pensions."
  • Shipping list no. not available
  • Distributed to some depository libraries in microfiche
Bibliography note
Includes bibliographical references
Carrier category
volume
Carrier category code
nc
Carrier MARC source
rdacarrier
Content category
text
Content type code
txt
Content type MARC source
rdacontent
Dimensions
24 cm.
Extent
iii, 93 pages
Isbn
9780160726897
Media category
unmediated
Media MARC source
rdamedia
Media type code
n
Other physical details
illustrations
System control number
  • ocm61285647
  • (GPO)99174516
Label
FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [sic] meets standards for safety and efficacy, March 1, 2005
Link
http://purl.access.gpo.gov/GPO/LPS63058
Publication
Note
  • "Printed for the use of the Committee on Health, Education, Labor, and Pensions."
  • Shipping list no. not available
  • Distributed to some depository libraries in microfiche
Bibliography note
Includes bibliographical references
Carrier category
volume
Carrier category code
nc
Carrier MARC source
rdacarrier
Content category
text
Content type code
txt
Content type MARC source
rdacontent
Dimensions
24 cm.
Extent
iii, 93 pages
Isbn
9780160726897
Media category
unmediated
Media MARC source
rdamedia
Media type code
n
Other physical details
illustrations
System control number
  • ocm61285647
  • (GPO)99174516

Library Locations

    • Main LibraryBorrow it
      310 North Tryon Street, Charlotte, NC, 28202, US
      35.2285213 -80.8421167
Processing Feedback ...